{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:48:42Z","timestamp":1790732922089,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK065988"],"award-info":[{"award-number":["DK065988"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HARRIS14XX0"],"award-info":[{"award-number":["HARRIS14XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 006"],"award-info":[{"award-number":["SRC 006"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.omtm.2023.101140","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:51:35Z","timestamp":1697629895000},"page":"101140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing"],"prefix":"10.1016","volume":"31","author":[{"given":"Amy J.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximillian","family":"Woodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhina","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"O\u2019Hara-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad M.","family":"Aldossary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-376X","authenticated-orcid":false,"given":"Stephen L.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.101140_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4997\/JRCPE.2013.212","article-title":"Cystic Fibrosis","volume":"43","author":"Leitch","year":"2013","journal-title":"J.\u00a0R. Coll. Physicians Edinb."},{"key":"10.1016\/j.omtm.2023.101140_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.omtm.2023.101140_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.omtm.2023.101140_bib4","series-title":"The Metabolic Basis of Inherited Disease","first-page":"2649","article-title":"Cystic fibrosis","author":"Boat","year":"1989"},{"key":"10.1016\/j.omtm.2023.101140_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pharmthera.2016.11.009","article-title":"New horizons for cystic fibrosis treatment","volume":"170","author":"Fajac","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18180","article-title":"Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis","volume":"18","author":"Whiting","year":"2014","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.omtm.2023.101140_bib7","doi-asserted-by":"crossref","first-page":"L1117","DOI":"10.1152\/ajplung.00169.2005","article-title":"Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules","volume":"290","author":"Van Goor","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtm.2023.101140_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101140_bib9","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2023.101140_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prrv.2013.01.006","article-title":"CFTR2: How will it help care?","volume":"14","author":"Castellani","year":"2013","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.omtm.2023.101140_bib11","series-title":"CFF. 2019 Patient Registry Annual Data Report","year":"2019"},{"key":"10.1016\/j.omtm.2023.101140_bib12","series-title":"Patient registry report 2018","year":"2018"},{"key":"10.1016\/j.omtm.2023.101140_bib13","doi-asserted-by":"crossref","first-page":"662110","DOI":"10.3389\/fphar.2021.662110","article-title":"On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis","volume":"12","author":"Ensinck","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtm.2023.101140_bib14","doi-asserted-by":"crossref","first-page":"32230","DOI":"10.1038\/srep32230","article-title":"Analysis of gene repair tracts from Cas9\/gRNA double-stranded breaks in the human CFTR gene","volume":"6","author":"Hollywood","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib15","first-page":"974","article-title":"A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations","volume":"331","author":"Highsmith","year":"1994","journal-title":"J.\u00a0Med."},{"key":"10.1016\/j.omtm.2023.101140_bib16","doi-asserted-by":"crossref","first-page":"e0184009","DOI":"10.1371\/journal.pone.0184009","article-title":"Cas9\/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA","volume":"12","author":"Sanz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.101140_bib17","doi-asserted-by":"crossref","first-page":"L258","DOI":"10.1152\/ajplung.00471.2016","article-title":"BMI-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity","volume":"312","author":"Munye","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtm.2023.101140_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41598-017-00662-2","article-title":"Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis","volume":"7","author":"Manunta","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib19","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.ymthe.2018.09.004","article-title":"Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery","volume":"26","author":"Fernando","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thoraxjnl-2017-210670","article-title":"Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung","volume":"73","author":"Tagalakis","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.omtm.2023.101140_bib21","doi-asserted-by":"crossref","first-page":"21881","DOI":"10.1038\/srep21881","article-title":"Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis","volume":"6","author":"Yu-Wai-Man","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/mt.2008.38","article-title":"A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer","volume":"16","author":"Tagalakis","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib23","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1038\/srep09292","article-title":"Role of liposome and peptide in the synergistic enhancement of transfection with a lipopolyplex vector","volume":"5","author":"Munye","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10611860410001724459","article-title":"Targeted Gene Delivery to Human Airway Epithelial Cells with Synthetic Vectors Incorporating Novel Targeting Peptides Selected by Phage Display","volume":"12","author":"Writer","year":"2004","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.omtm.2023.101140_bib25","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1038\/srep07107","article-title":"The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations","volume":"4","author":"Du","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.biomaterials.2010.10.037","article-title":"Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration","volume":"32","author":"Tagalakis","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2023.101140_bib27","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1016\/j.biomaterials.2011.05.022","article-title":"Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery","volume":"32","author":"Tagalakis","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2023.101140_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-1759(01)00474-4","article-title":"Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores","volume":"258","author":"Wilkinson","year":"2001","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.omtm.2023.101140_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in\u00a0vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2023.101140_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.101140_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12864-017-3746-y","article-title":"GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases","volume":"18","author":"Zhu","year":"2017","journal-title":"BMC Genom."},{"key":"10.1016\/j.omtm.2023.101140_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/geno.1998.5517","article-title":"The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation","volume":"53","author":"Chiba-Falek","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.omtm.2023.101140_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nm0195-39","article-title":"Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"1","author":"Caplen","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2023.101140_bib34","first-page":"1113","article-title":"Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP","volume":"3","author":"McLachlan","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.gt.3300391","article-title":"A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Gill","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/hum.1998.9.2-249","article-title":"A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Hum","volume":"9","author":"Knowles","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.gt.3301212","article-title":"Repeat administration of DNA\/liposomes to the nasal epithelium of patients with cystic fibrosis","volume":"7","author":"Hyde","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.1999.0009","article-title":"Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis","volume":"1","author":"Noone","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1183\/09031936.94.07030442","article-title":"Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth","volume":"7","author":"Middleton","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtm.2023.101140_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.omtm.2023.101140_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtm.2023.101140_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2023.101140_bib44","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-019-11454-9","article-title":"Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing","volume":"10","author":"Maule","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.101140_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.omtn.2019.02.006","article-title":"Efficient Gene Editing at Major CFTR Mutation Loci. Molecular therapy","volume":"16","author":"Ruan","year":"2019","journal-title":"Nucleic acids"},{"key":"10.1016\/j.omtm.2023.101140_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.stem.2019.11.002","article-title":"High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia","volume":"26","author":"Vaidyanathan","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2023.101140_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","article-title":"Readthrough compounds for nonsense mutations: bridging the translational gap","volume":"29","author":"Spelier","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2023.101140_bib48","doi-asserted-by":"crossref","first-page":"e1000155","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"Zhang","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2023.101140_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41434-022-00332-7","article-title":"Effective viral-mediated lung gene therapy: is airway surface preparation necessary?","volume":"30","author":"McCarron","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101140_bib50","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acschembio.0c00003","article-title":"Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs","volume":"15","author":"Li","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtm.2023.101140_bib51","doi-asserted-by":"crossref","first-page":"e1801151","DOI":"10.1002\/adma.201801151","article-title":"Ionizable Amino-Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino-Alcohols for Tissue Selective mRNA Delivery","volume":"30","author":"Kowalski","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtm.2023.101140_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/nat.2019.0790","article-title":"Evaluation and Reduction of CRISPR Off-Target Cleavage Events","volume":"29","author":"Vakulskas","year":"2019","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtm.2023.101140_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 Protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J.\u00a0Pharmaceut. Sci."},{"key":"10.1016\/j.omtm.2023.101140_bib54","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1093\/nar\/gkab788","article-title":"Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors","volume":"49","author":"Krishnamurthy","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2023.101140_bib55","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.omtm.2020.05.002","article-title":"Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing","volume":"17","author":"Erwood","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.101140_bib56","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.101140_bib57","doi-asserted-by":"crossref","first-page":"16776","DOI":"10.1038\/s41598-018-34960-0","article-title":"Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis","volume":"8","author":"Haque","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib58","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","article-title":"Advances in gene therapy for cystic fibrosis lung disease","volume":"28","author":"Yan","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib59","first-page":"623","article-title":"A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype","volume":"56","author":"Chill\u00f3n","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T","article-title":"Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane","volume":"14","author":"Beck","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2023.101140_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2012-0371OC","article-title":"Fine Characterization of the Recurrent c.1584+18672A>G Deep-Intronic Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene","volume":"48","author":"Costantino","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2023.101140_bib62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ajhg.2017.04.001","article-title":"Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites","volume":"100","author":"Lee","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib63","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","volume":"136","author":"Vaz-Drago","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib64","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1073\/pnas.81.9.2821","article-title":"beta-Thalassemia in Chinese: use of in\u00a0vivo RNA analysis and oligonucleotide hybridization in systematic characterization of molecular defects","volume":"81","author":"Cheng","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.101140_bib65","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-1809.2009.00546.x","article-title":"A mutation that creates a pseudoexon in SOD1 causes familial ALS","volume":"73","author":"Valdmanis","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) Gene Are a Frequent Cause of Leber Congenital Amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2023.101140_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2023.101140_bib68","doi-asserted-by":"crossref","first-page":"L82","DOI":"10.1152\/ajplung.90314.2008","article-title":"Novel human bronchial epithelial cell lines for cystic fibrosis research","volume":"296","author":"Fulcher","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtm.2023.101140_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR Edits from Sanger Trace Data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtm.2023.101140_bib70","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2023.101140_bib71","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41598-018-19441-8","article-title":"A Survey of Validation Strategies for CRISPR-Cas9 Editing","volume":"8","author":"Sentmanat","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2023.101140_bib72","doi-asserted-by":"crossref","first-page":"e0124633","DOI":"10.1371\/journal.pone.0124633","article-title":"CCTop: An Intuitive, Flexible and Reliable CRISPR\/Cas9 Target Prediction Tool","volume":"10","author":"Stemmer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.101140_bib73","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2023.101140_bib74","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A Web-based Tool for Identifying and Validating CRISPR\/Cas Off-target Sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:22:07Z","timestamp":1762615327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":74,"alternative-id":["S2329050123001791"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101140","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101140"}}